Arvaya Healthcare Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 16 shares,. Its Average Traded Price (ATP) is ₹110.51, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 5 @ ₹109.00.
Arvaya Healthcare has an upper circuit limit of ₹116.75 and a lower circuit limit of ₹105.65. The total value traded stands at ₹1768.16, and the delivery percentage for the day is 0%.
The stock is currently traded with a market lot size of 1. Arvaya Healthcare also offers a dividend yield of 0%.
Arvaya Healthcare Share Price Chart
Arvaya Healthcare Share Key Metrics
Volume
16.00
Market Cap
565.64 CR
LTQ@LTP
5@109.00
ATP
110.51
Var Margin
100 %
Circuit Range
105.65-116.75
Delivery %
0 %
Value
1768.16
ASM/GSM
No
Market Lot
1
Arvaya Healthcare Resistance and Support
Pivot 111.2
Resistance
First Resistance
111.2
Second Resistance
111.2
Third Resistance
111.2
Support
First Support
111.2
Second Support
111.2
Third Support
111.2
Arvaya Healthcare Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Arvaya Healthcare Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-13 | Quarterly Results |
| 2026-11-04 | Others |
| 2026-10-24 | Others |
| 2026-08-26 | Others |
| 2026-08-12 | Quarterly Results |
| 2026-07-11 | Rights & Pref. issue of Equity Shares |
| 2026-07-04 | Others |
| 2026-05-28 | Audited Results |
| 2026-03-17 | Others |
| 2026-03-11 | Others |
| 2026-03-04 | Others |
| 2026-02-13 | Quarterly Results |
| 2025-11-04 | Quarterly Results & Others |
| 2025-09-26 | Voluntary Delisting of Shares |
| 2025-07-28 | Quarterly Results & Others |
| 2025-05-26 | Audited Results & Dividend |
| 2025-03-28 | Independent Director Meeting |
| 2025-02-04 | Quarterly Results |
| 2025-01-07 | Others |
| 2024-12-26 | Preferential Issue of shares & Others |
| 2024-11-09 | Quarterly Results |
| 2024-10-08 | Others |
| 2024-08-21 | Others |
| 2024-08-13 | Quarterly Results |
| 2024-07-26 | Others |
Arvaya Healthcare News
Arvaya Healthcare Ltd - 524723 - Board Meeting Intimation for Board Meeting Intimation Under Regulation 29(1) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Arvaya Healthcare board of directors will meet on November 13, 2026. The primary agenda is the approval of the financial results.
Nov 08 2026 23:53:57
Arvaya Healthcare Ltd - 524723 - Outcome Of The Meeting Of The Rights Issue Committee Of The Board Of Directors Held On Friday, November 06, 2026 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Arvaya Healthcare approved the draft letter of offer for its rights issue aggregating up to Rs.205.80 crores. The issue consists of partly paid-up equity shares, and the company will seek in-principle listing approval from BSE.
Nov 06 2026 18:58:27
Arvaya Healthcare Ltd - 524723 - Revised Outcome For Board Meeting Dated 04 November 2026
Arvaya Healthcare's board has authorised the Rights Issue Committee to adopt the Draft Letter of Offer for a proposed rights issue of up to Rs.210 crore. The final issue price, entitlement ratio, and record date will be decided later.
Nov 05 2026 17:54:39
Arvaya Healthcare Ltd - 524723 - Board Meeting Outcome for Board Meeting Outcome For The Meeting Dated 4Th November 2026 Held Through Through Video Conferencing/Other Audio-Visual Means
Arvaya Healthcare's board has approved the draft letter of offer for a rights issue of partly paid-up equity shares aggregating up to ₹210 crore. The final terms, including the issue price and record date, will be decided by the committee in due course.
Nov 04 2026 18:42:46
Arvaya Healthcare Ltd - 524723 - Announcement under Regulation 30 (LODR)-Acquisition
Arvaya Healthcare has completed the acquisition of 1,84,374 equity shares, representing 100% of the equity share capital of Sushodha Institute of Gastroenterology Private Limited. The acquired entity is now a wholly-owned subsidiary effective November 1, 2026.
Nov 01 2026 18:54:55
Arvaya Healthcare Ltd - 524723 - Board Meeting Intimation for Prior Intimation Of The Board Meeting Pursuant To Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Arvaya Healthcare's board is scheduled to meet on November 4, 2026. The agenda includes approval of the Draft Letter of Offer and objects for its proposed Rights Issue, as well as material related party transactions.
Oct 29 2026 17:08:32
Arvaya Healthcare Ltd - 524723 - Disclosure Under Regulation 7(2)(A) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015
Executive Director Bidari Kotresh Anilkumar acquired 5,91,129 shares (0.87% stake) in Arvaya Healthcare through a preferential share swap. His total holding now stands at 4.45%.
Oct 24 2026 18:30:01
Arvaya Healthcare Ltd - 524723 - Announcement under Regulation 30 (LODR)-Allotment
Arvaya Healthcare approved the allotment of 38.71 lakh equity shares at an issue price of Rs.40 per share. The preferential allotment is made to shareholders of Sushodha Institute of Gastroenterology for consideration other than cash via a share swap.
Oct 24 2026 18:01:55
Arvaya Healthcare Ltd - 524723 - Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Of Arvaya Healthcare Limited (Formerly Known As Bijoy Hans Limited) Held On 24Th October 2026
Arvaya Healthcare's board approved the preferential allotment of 38,71,854 equity shares at ₹40 each, aggregating to ₹15.48 crores. The shares are allotted to the shareholders of Sushodha Institute of Gastroenterology Private Limited on a share swap basis for a consideration other than cash.
Oct 24 2026 17:49:38
Arvaya Healthcare Ltd - 524723 - Board Meeting Intimation for To Consider And Approve The Allotment Of 38,71,854 Equity Shares Of The Company To The Shareholders Of Sushodha Institute Of Gastroenterology Private Limited ('SIGPL') On Preferential Basis For Consideration Other Than Cash.
Arvaya Healthcare's board is scheduled to meet on October 24, 2026. The primary agenda is to consider the preferential allotment of 38.71 lakh equity shares to the shareholders of Sushodha Institute of Gastroenterology Private Limited for a non-cash consideration.
Oct 17 2026 18:02:40
Arvaya Healthcare Management
| Name | Position |
|---|---|
| Guinea Agrawal | Company Secretary & Compliance Officer |
| Salil Sriram Shetty | Non Executive Independent Director |
Arvaya Healthcare Similar Stocks
Fabtech Technologies Ltd.
143.90
4.25 (3.04%)
NR Agarwal Industries Ltd.
671.70
13.40 (2.04%)
Subam Papers Ltd.
216.00
0.00 (0.00%)
HT Media Ltd.
24.51
0.11 (0.45%)
Mallcom (India) Ltd
939.50
9.50 (1.02%)
Sharat Industries Ltd.
141.60
-0.20 (0.14%)
BMW Ventures Ltd.
66.00
1.17 (1.80%)
Universus Photo Imagings Ltd.
498.00
0.00 (0.00%)
SK Minerals & Additives Ltd.
438.00
-4.05 (0.92%)
Arvaya Healthcare FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in ARVAYA
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC